SIVAD Global Health LLC is a minority-owned company with headquarters in Delaware.
Our senior management is a unique combination of seasoned businessmen, global logistics experts, high-tech specialists, clinicians, and researchers.
Lenzie Davis, Sr: President and CEO Entrepreneur and international business manager: 45+ years of experience including: Large-scale office automation; capital infrastructure (roads, sewage, etc.) in West Africa; large-scale VOIP-based communications internationally; large-scale cellular communications in Africa and Caribbean; manufacturing, and global distribution
Harold Mignott, MD: Chief Medical Officer M.D. Degree, the University of Pennsylvania School of Medicine; faculty for 25 years at the University of Pennsylvania School of Medicine; board certified in Internal Medicine; named one of the most influential African Americans in Philadelphia; recipient of the Sylvan Eisman Outstanding Primary Care Physician in the University of Pennsylvania Health System; recipient of the Award John Eisenberg Teaching
Kevin Weller: VP Global Strategy 20+ years in solution development in the pharmaceutical and diagnostic sectors; big data analyst for structured data and unstructured data; extensive experience in AI-augmented medical information systems; extensive experience in datamining; extensive experiences in leveraging cutting-edge technologies to solve complex healthcare problems; extensive experience with synchronous and asynchronous training programs globally; certifications include Microsoft, Veeva, AWS, IQVIA/IMS, Adobe, IBM, AWS, FDA/DIA, AI, HIPAA, GDPR, CCPA.
Joseph Scrocco, MS, MA, MBA: VP Clinical Product Development MS neurophysiology, MA Distributed Information Systems, MBA; 25 years in pharmaceutical and diagnostics; Lead solutions architect for over 20 global enterprise solutions; certifications include Microsoft, Siebel, Salesforce, Veeva, AWS, IQVIA/IMS, Adobe, IBM, AWS, FDA/DIA, AI, HIPAA, GDPR, CCPA, Six Sigma and Lean, PMBOK; extensive experience in multiple therapy areas including: Diabetes (type 1 and type 2), infections disease – diagnostics and therapeutics, rare diseases, growth disorders, women's health, oncology, erectile dysfunction, hematology; significant technology experience in business analysis, systems architecture, project management, programmer/developer, DBA, UI/UX specialist.
Henri du Pont: Vice President of Business Development 30 years of experience in research, technology, sales, and business development formation; industries include energy, injection molding, polymers, finance, IT, manufacturing, consumer products, and enterprise solutions, VoIP and biometrics; HIPAA and Sarbanes-Oxley compliance; party to the first Property Assessed Clean Energy or PACE; infectious disease mitigation (including COVID-19) – personal, building, and environmental; from a young age, worked in complex environments with E. I. DuPont, the family company